{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:44:45Z","timestamp":1782729885084,"version":"3.54.5"},"reference-count":20,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V107B-036"],"award-info":[{"award-number":["V107B-036"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Health and Welfare","award":["MOHW107-TDU-B-211-114019"],"award-info":[{"award-number":["MOHW107-TDU-B-211-114019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40425-018-0388-9","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T14:30:17Z","timestamp":1531751417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Sick sinus syndrome associated with anti-programmed cell death-1"],"prefix":"10.1136","volume":"6","author":[{"given":"Chien-Yi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9436-5400","authenticated-orcid":false,"given":"San-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"issue":"2","key":"388_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"},{"issue":"16","key":"388_CR2","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","volume":"71","author":"SS Mahmood","year":"2018","unstructured":"Mahmood SS, Fradley MG, Cohen JV, et al. Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol. 2018;71(16):1755\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"388_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ctrv.2017.06.002","volume":"58","author":"M Sznol","year":"2017","unstructured":"Sznol M, Postow MA, Davies MJ, et al. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017;58:70\u20136.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"388_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","volume":"4","author":"R Barroso-Sousa","year":"2018","unstructured":"Barroso-Sousa R, Barry WT, Garrido-Castro AC, et al. Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis. JAMA Oncol. 2018;4(2):173\u201382.","journal-title":"JAMA Oncol"},{"key":"388_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40425-016-0152-y","volume":"4","author":"L Heinzerling","year":"2016","unstructured":"Heinzerling L, Ott PA, Hodi FS, et al. Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy. J Immunother Cancer. 2016;4:50.","journal-title":"J Immunother Cancer"},{"issue":"18","key":"388_CR6","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","volume":"375","author":"DB Johnson","year":"2016","unstructured":"Johnson DB, Balko JM, Compton ML, et al. Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med. 2016;375(18):1749\u201355.","journal-title":"N Engl J Med"},{"issue":"10","key":"388_CR7","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.4049\/jimmunol.1200389","volume":"188","author":"ML Tarrio","year":"2012","unstructured":"Tarrio ML, Grabie N, Bu DX, et al. PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis. J Immunol. 2012;188(10):4876\u201384.","journal-title":"J Immunol"},{"issue":"3","key":"388_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/00365510802676848","volume":"69","author":"KM Henningsen","year":"2009","unstructured":"Henningsen KM, Therkelsen SK, Bruunsgaard H, et al. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion. Scand J Clin Lab Invest. 2009;69(3):425\u201332.","journal-title":"Scand J Clin Lab Invest"},{"issue":"21","key":"388_CR9","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","volume":"50","author":"TT Issac","year":"2007","unstructured":"Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50(21):2021\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"388_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10840-013-9792-8","volume":"37","author":"A Rubaj","year":"2013","unstructured":"Rubaj A, Rucinski P, Kutarski A, et al. Cardiac hemodynamics and proinflammatory cytokines during biatrial and right atrial appendage pacing in patients with interatrial block. J Interv Card Electrophysiol. 2013;37(2):147\u201354.","journal-title":"J Interv Card Electrophysiol"},{"issue":"4","key":"388_CR11","doi-asserted-by":"publisher","first-page":"e000247","DOI":"10.1136\/esmoopen-2017-000247","volume":"2","author":"G Varricchi","year":"2017","unstructured":"Varricchi G, Galdiero MR, Marone G, et al. Cardiotoxicity of immune checkpoint inhibitors. ESMO Open. 2017;2(4):e000247.","journal-title":"ESMO Open"},{"key":"388_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2018.04.001","volume":"97","author":"S Hescot","year":"2018","unstructured":"Hescot S, Haissaguerre M, Pautier P, et al. Immunotherapy-induced Addison's disease: a rare, persistent and potentially lethal side-effect. Eur J Cancer. 2018;97:57\u20138.","journal-title":"Eur J Cancer"},{"issue":"3","key":"388_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","volume":"3","author":"I Bancos","year":"2015","unstructured":"Bancos I, Hahner S, Tomlinson J, et al. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015;3(3):216\u201326.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"20","key":"388_CR14","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.2169\/internalmedicine.53.2726","volume":"53","author":"K Kanamori","year":"2014","unstructured":"Kanamori K, Yamashita R, Tsutsui K, et al. Long QT syndrome associated with adrenal insufficiency in a patient with isolated adrenocorticotropic hormone deficiency. Intern Med. 2014;53(20):2329\u201331.","journal-title":"Intern Med"},{"issue":"9829","key":"388_CR15","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/S0140-6736(12)60314-6","volume":"379","author":"JD Lane","year":"2012","unstructured":"Lane JD, Keenan NG, Bouloux P, et al. A heart without hormones. Lancet. 2012;379(9829):1922.","journal-title":"Lancet"},{"issue":"6","key":"388_CR16","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00380-015-0660-6","volume":"31","author":"J Komuro","year":"2016","unstructured":"Komuro J, Kaneko M, Ueda K, et al. Adrenal insufficiency causes life-threatening arrhythmia with prolongation of QT interval. Heart Vessel. 2016;31(6):1003\u20135.","journal-title":"Heart Vessel"},{"issue":"9","key":"388_CR17","doi-asserted-by":"publisher","first-page":"1167 e1","DOI":"10.1016\/j.ajem.2008.12.001","volume":"27","author":"S Nishizawa","year":"2009","unstructured":"Nishizawa S, Nakamura T, Hamaoka T, et al. Lethal arrhythmia and corticosteroid insufficiency. Am J Emerg Med. 2009;27(9):1167 e1\u20133.","journal-title":"Am J Emerg Med"},{"issue":"6","key":"388_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/01.RES.75.6.1006","volume":"75","author":"K Takimoto","year":"1994","unstructured":"Takimoto K, Levitan ES. Glucocorticoid induction of Kv1.5 K+ channel gene expression in ventricle of rat heart. Circ Res. 1994;75(6):1006\u201313.","journal-title":"Circ Res"},{"issue":"21","key":"388_CR19","doi-asserted-by":"publisher","first-page":"15075","DOI":"10.1074\/jbc.M113.453670","volume":"288","author":"SM Lamothe","year":"2013","unstructured":"Lamothe SM, Zhang S. The serum- and glucocorticoid-inducible kinases SGK1 and SGK3 regulate hERG channel expression via ubiquitin ligase Nedd4-2 and GTPase Rab11. J Biol Chem. 2013;288(21):15075\u201384.","journal-title":"J Biol Chem"},{"issue":"1","key":"388_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0022-2828(83)90303-6","volume":"15","author":"N Narayanan","year":"1983","unstructured":"Narayanan N. Effects of adrenalectomy and in vivo administration of dexamethasone on ATP-dependent calcium accumulation by sarcoplasmic reticulum from rat heart. J Mol Cell Cardiol. 1983;15(1):7\u201315.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-018-0388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-018-0388-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-018-0388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:43:48Z","timestamp":1601055828000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-018-0388-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1186\/s40425-018-0388-9","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"7 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study has been reviewed by the institutional review board of Taipei Veterans General Hospital, which is the appropriate regulatory agency to review research on both adults and children. (VGHTPE-IRB: 2017\u201310-005\u00a0BC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"72"}}